Compare Enveric Biosciences Inc (ENVB) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Zoetis Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Zoetis Inc trades at $75 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 5022.6× Enveric Biosciences Inc's market cap, and Zoetis Inc pays a 2.81% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | ZTS | |
|---|---|---|
Market Cap | $6.20M | $31.14B |
Sector | Health | Health |
52-Week High | $17.40 | $156.76 |
52-Week Low | $1.27 | $71.91 |
Enterprise Value | $1.30M | $38.70B |
Dividend Yield | — | 2.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
